PET imaging
personalized treatment
imaging-guided treatment optimization
treatment initiation
treatment responses
Personalized Tailored Treatment Objectives
Cardiovascular Molecular Imaging
Magnetic Resonance Imaging
imaging-guided dose-derived therapeutic concepts
appropriate drug dose
HF pathophysiology
Wistar rats
dedicated small animal system
single cardiac PET scan
neurohumoral system alterations
novel AT1-ligand
given HF patient
multiple set of cardioneuronal PET tracers
new concept of individualized drug dose determination
molecular level
EU economy
small animal model of myocardial infarction
regional neurohumoral abnormalities
radiolabelled novel angiotensin
subsequent left ventricular remodelling
deterioration of ventricular geometric parameters
rat hearts
proposal
partner institution
blocker analogue
receptor
potential
different degrees of ischemic insult
highest pharmaceutical doses of antiRAS agents
microPET
extent of global
cutting-edge method
Heart Failure
clinic
effects
Johns Hopkins University
future
ligation
coronary artery
relationship
mciroPET
expensive diseases
long term perspective
Positron emission tomography
technique
patientsâ€™ quality of life
reduction
economic burden
Relevance
Work Programme
year
study
aim